This modulation resulted in altered expression of the downstream signaling molecules mTOR, Bcl-2, and Bad, thereby inhibiting the protein expression of caspase3 and Bax, while upregulating the anti-apoptotic gene Bcl-2 to counteract DOX-induced CHF. The gene discussed is BCL2; the disease is congestive heart failure.